Pharmacological Basis for Use of a Novel Compound in Hyperuricemia: Anti-Hyperuricemic and Anti-Inflammatory Effects
Background: The prevalence of hyperuricemia is considered high worldwide. Hyperuricemia occurs due to decreased excretion of uric acid, increased synthesis of uric acid, or a combination of both mechanisms. There is growing evidence that hyperuricemia is associated with a decline of renal function.P...
Guardado en:
Autores principales: | Lei Zhao, Yihang Li, Dahong Yao, Ran Sun, Shifang Liu, Xi Chen, Congcong Lin, Jian Huang, Jinhui Wang, Guang Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/018f207a970e46d797dc7c607f7200e7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hyperuricemia as a Risk Factor for Cardiovascular Diseases
por: Ichiro Hisatome, et al.
Publicado: (2020) -
Standardization of Diploid <i>Codonopsis laceolata</i> Root Extract as an Anti-Hyperuricemic Source
por: Seung-Yub Song, et al.
Publicado: (2021) -
Management of hyperuricemia in gout: focus on febuxostat
por: Mattheus K Reinders, et al.
Publicado: (2010) -
Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
por: Yousuf Waheed, et al.
Publicado: (2021) -
Active Flavonoids From Lagotis brachystachya Attenuate Monosodium Urate-Induced Gouty Arthritis via Inhibiting TLR4/MyD88/NF-κB Pathway and NLRP3 Expression
por: Xiang Ouyang, et al.
Publicado: (2021)